Dottikon set to boost drug ingredient output

2020 ◽  
Vol 98 (42) ◽  
pp. 12-13
Author(s):  
Rick Mullin
Keyword(s):  
Drug Ingredient

Solution Properties and Phase Behavior of Ammonium Hexylene Octyl Succinate in Water and Water-Oil System

1970 ◽  
Vol 3 (1) ◽  
Author(s):  
Md. Hamidul Kabir ◽  
Ravshan Makhkamov ◽  
Shaila Kabir
Keyword(s):  
Critical Micelle Concentration ◽  
Phase Behavior ◽  
Liquid Crystalline ◽  
Carbon Number ◽  
Phase Region ◽  
Solution Properties ◽  
Middle Phase ◽  
Two Phase ◽  
Lamellar Liquid Crystal ◽  
Drug Ingredient

The solution properties and phase behavior of ammonium hexylene octyl succinate (HOS) was investigated in water and water-oil system. The critical micelle concentration (CMC) of HOS is lower than that of anionic surfactants having same carbon number in the lipophilic part. The phase diagrams of a water/ HOS system and water/ HOS/ C10EO8/ dodecane system were also constructed. Above critical micelle concentration, the surfactant forms a normal micellar solution (Wm) at a low surfactant concentration whereas a lamellar liquid crystalline phase (La) dominates over a wide region through the formation of a two-phase region (La+W) in the binary system. The lamellar phase is arranged in the form of a biocompatible vesicle which is very significant for the drug delivery system. The surfactant tends to be hydrophilic when it is mixed with C10EO8 and a middle-phase microemulsion (D) is appeared in the water-surfactant-dodecane system where both the water and oil soluble drug ingredient can be incorporated in the form of a dispersion. Hence, mixing can tune the hydrophile-lipophile properties of the surfactant. Key words: Ammonium hexylene octyl succinate, mixed surfactant, lamellar liquid crystal, middle-phase microemulsion. Dhaka Univ. J. Pharm. Sci. Vol.3(1-2) 2004 The full text is of this article is available at the Dhaka Univ. J. Pharm. Sci. website

Use of Near-Infrared–Mid-Infrared Dual-Wavelength Spectrometry to Obtain Two-Dimensional Difference Spectra of Sesame Oil as Inactive Drug Ingredient

2020 ◽  
pp. 000370282096919
Author(s):  
Masahiro Watari ◽  
Akifumi Nagamoto ◽  
Takuma Genkawa ◽  
Shigeaki Morita
Keyword(s):  
Room Temperature ◽  
Near Infrared ◽  
Sesame Oil ◽  
Partial Least Square ◽  
Dual Wavelength ◽  
Two Dimensional ◽  
Difference Spectra ◽  
Mid Infrared ◽  
Starting Point ◽  
Drug Ingredient

The present study has investigated the transformation of sesame oil kept at low temperature during a definite period of time for refinement (called winterization) as an inactive drug ingredient by using two-dimensional difference spectra (2D-DS) analysis of spectra collected using a near-infrared (NIR) and mid-infrared (MIR) dual-wavelength spectrometer (NIR–MIR-DWS). The NIR and MIR spectra were measured nearly simultaneously from samples of sesame oil before and after winterization. The difference spectrum analysis of the obtained NIR–MIR data elucidated that, after the winterization process, the absorbances at peaks attributed to C=O, C=C, and OH groups decrease while the absorbances arising from the main chain (CH2) increase. The result indicated the removal of lignan and the fatty acids with relatively short main chains. Moreover, sesame oil unwinterized was cooled from room temperature to near 1 ℃ and subsequently warmed to room temperature. And the cycle was repeated two times. Real-time monitoring during the cooling and warming processes were carried out using the NIR-MIR-DWS. The prediction results obtained from partial least square calibration model for the temperature suggests that there are subtle differences in the oil composition between the first cooling process and after the warming and cooling cycle. For the more detailed analysis, the 2D-DS method is proposed. The results of the analyses using 2D-DS revealed that the starting point of the transformation is around 15 ℃. It can be estimated that sesame oil is mainly transformed by the first cooling down. Moreover, it was implied that the structure of methylene (CH2) was significantly related to the modifications in sesame oil with temperature change. A series of experimental results elucidated that the winterization of sesame oil removed its impurities and stabilized its conditions. These results are probably the first report on the effect of the winterization process on sesame oil.

scholarly journals Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula “Goshajinkigan”

2019 ◽  
Vol 73 (4) ◽  
pp. 761-768 ◽  
Author(s):  
Kazufumi Toume ◽  
Zhiyan Hou ◽  
Huanhuan Yu ◽  
Mitsuru Kato ◽  
Miki Maesaka ◽  
...  
Keyword(s):  
Crude Drug ◽  
Drug Ingredient ◽  
Plantaginis Semen

scholarly journals Suspended particle and drug ingredient concentrations in hospital dispensaries and implications for pharmacists’ working environments

2015 ◽  
Vol 21 (2) ◽  
pp. 105-110 ◽  
Author(s):  
Ryoichi Inaba ◽  
Atsushi Hioki ◽  
Yoshihiro Kondo ◽  
Hiroki Nakamura ◽  
Mitsuhiro Nakamura
Keyword(s):  
Suspended Particle ◽  
Working Environments ◽  
Drug Ingredient

Final Safety Assessment of Coal Tar as Used in Cosmetics

2008 ◽  
Vol 27 (2_suppl) ◽  
pp. 1-24 ◽  
Keyword(s):  
Weight Loss ◽  
Biological Effect ◽  
Safety Assessment ◽  
Rank Order ◽  
Coal Tar ◽  
Reproductive Toxicity ◽  
Polycyclic Aromatic ◽  
Drug Ingredient ◽  
Epidemiology Studies ◽  
Risk Of Cancer

Coal Tar is a semisolid by-product obtained in the destructive distillation of bituminous coal, which functions in cosmetic products as a cosmetic biocide and denaturant—antidandruff agent is also listed as a function, but this is considered an over-the-counter (OTC) drug use. Coal Tar is a nearly black, viscous liquid, heavier than water, with a naphthalene-like odor and a sharp burning taste, produced in coking ovens as a by-product in the manufacture of coke. Crude Coal Tar is composed of 48% hydrocarbons, 42% carbon, and 10% water. In 2002, Coal Tar was reported to the Food and Drug Administration (FDA) to be used in four formulations, all of which appear to be OTC drug products. Coal Tar is monographed by the FDA as Category I (safe and effective) OTC drug ingredient for use in the treatment of dandruff, seborrhoea, and psoriasis. Coal Tar is absorbed through the skin of animals and humans and is systemically distributed. In short-term studies, mice fed a diet containing Coal Tar found it unpalatable, but no adverse effects were reported other than weight loss; rats injected with Coal Tar experienced malaise in one study and decreased water intake and increased liver weights in another; rabbits injected with Coal Tar residue experienced eating avoidance, respiratory difficulty, sneezing, and weight loss. In a subchronic neurotoxicity study using mice, a mixture of phenols, cresols, and xylenols at concentrations approximately equal to those expected in Coal Tar extracts produced regionally selective effects, with a rank order of corpus striatum > cerebellum > cerebral cortex. Coal Tar applied to the backs of guinea pigs increases epidermal thickness. Painting female rabbits with tar decreases the absolute and relative weights of the ovaries and decreased the number of interstitial cells in the ovary. Four therapeutic Coal Tar preparations used in the treatment of psoriasis were mutagenic in the Ames assay. Urine and blood from patients treated with Coal Tar were genotoxic in bacterial assays. Coal Tar was genotoxic in a mammalian genotoxicity assay and induced DNA adducts in various tissue types. Chronic exposure of mice to Coal Tar significantly decreased survival and liver neoplasms were seen in a significant dose-related trend; in other studies using mice lung tumors and perianal skin cancers were found. Coal Tar was comedogenic in three small clinical studies. Folliculitis is associated with the prolonged use of some tars. Several published reports describe cases of contact sensitivity to Coal Tar. Polycyclic aromatic hydrocarbons, which make up Coal Tar, are photosensitizers and cause phototoxicity by an oxygen-dependent mechanism. A retrospective study of the reproductive toxicity of Coal Tar in humans compared exposed women to controls and found little difference in spontaneous abortion and congenital disorders. Cancer epidemiology studies of patients who have received Coal Tar therapy of one form or other have failed to link treatment with an increase in the risk of cancer. Although the Cosmetic Ingredient Review (CIR) Expert Panel believes that Coal Tar use as an antidandruff ingredient in OTC drug preparations is adequately addressed by the FDA regulations, the Panel also believes that the appropriate concentration of use of Coal Tar in cosmetic formulations should be that level that does not have a biological effect in the user. Additional data needed to make a safety assessment include product types in which Coal Tar is used (other than as an OTC drug ingredient), use concentrations, and the maximum concentration that does not induce a biological effect in users.

Human Health Effects of Lactose Consumption as a Food and Drug Ingredient

2020 ◽  
Vol 26 (16) ◽  
pp. 1778-1789 ◽  
Author(s):  
Rafael G. Seoane ◽  
Verónica Garcia-Recio ◽  
Manuel Garrosa ◽  
María Á. Rojo ◽  
Pilar Jiménez ◽  
...  
Keyword(s):  
Premature Infants ◽  
Dairy Products ◽  
Lactose Intolerance ◽  
Pharmaceutical Formulations ◽  
Reducing Sugar ◽  
The Other ◽  
Lactase Deficiency ◽  
Adult Type ◽  
Drug Ingredient ◽  
Human Health Effects

: Lactose is a reducing sugar consisting of galactose and glucose, linked by a β (1→4) glycosidic bond, considered as an antioxidant due to its α-hydroxycarbonyl group. Lactose is widely ingested through the milk and other unfermented dairy products and is considered to be one of the primary foods. On the other hand, lactose is also considered as one of the most widely used excipients for the development of pharmaceutical formulations. In this sense, lactose has been related to numerous drug-excipient or drug-food pharmacokinetic interactions. : Intolerance, maldigestion and malabsorption of carbohydrates are common disorders in clinical practice, with lactose-intolerance being the most frequently diagnosed, afflicting 10% of the world’s population. Four clinical subtypes of lactose intolerance may be distinguished, namely lactase deficiency in premature infants, congenital lactase deficiency, adult-type hypolactasia and secondary lactase intolerance. An overview of the main uses of lactose in human nutrition and in the pharmaceutical industry and the problems derived from this circumstance are described in this review.

scholarly journals Pharmacokinetic and Metabolomic Studies with BIO 300, a Nanosuspension of Genistein, in a Nonhuman Primate Model

2019 ◽  
Vol 20 (5) ◽  
pp. 1231 ◽  
Author(s):  
Amrita Cheema ◽  
Khyati Mehta ◽  
Paola Santiago ◽  
Oluseyi Fatanmi ◽  
Michael Kaytor ◽  
...  
Keyword(s):  
Nonhuman Primate ◽  
Metabolite Profile ◽  
Ultra Performance Liquid Chromatography ◽  
Acute Radiation ◽  
Initial Assessment ◽  
Serum Samples ◽  
Primate Model ◽  
Delayed Effects ◽  
Flight Mass Spectrometry ◽  
Drug Ingredient

Genistein is a naturally occurring phytoestrogen isoflavone and is the active drug ingredient in BIO 300, a radiation countermeasure under advanced development for acute radiation syndrome (H-ARS) and for the delayed effects of acute radiation exposure (DEARE). Here we have assessed the pharmacokinetics (PK) and safety of BIO 300 in the nonhuman primate (NHP). In addition, we analyzed serum samples from animals receiving a single dose of BIO 300 for global metabolomic changes using ultra-performance liquid chromatography (UPLC) quadrupole time-of-flight mass spectrometry (QTOF-MS). We present a comparison of how either intramuscularly (im) or orally (po) administered BIO 300 changed the metabolomic profile. We observed transient alterations in phenylalanine, tyrosine, glycerophosphocholine, and glycerophosphoserine which reverted back to near-normal levels 7 days after drug administration. We found a significant overlap in the metabolite profile changes induced by each route of administration; with the po route showing fewer metabolic alterations. Taken together, our results suggest that the administration of BIO 300 results in metabolic shifts that could provide an overall advantage to combat radiation injury. This initial assessment also highlights the utility of metabolomics and lipidomics to determine the underlying physiological mechanisms involved in the radioprotective efficacy of BIO 300.

scholarly journals Molecular Targets and Mechanisms of Scutellariae radix-Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking

2021 ◽  
Vol 2021 ◽  
pp. 1-15
Author(s):  
Kai Niu ◽  
Qifang Li ◽  
Yuan Liu ◽  
Yi Qiao ◽  
Bingbing Li ◽  
...  
Keyword(s):  
Molecular Docking ◽  
Signaling Pathway ◽  
Active Ingredient ◽  
Enrichment Analysis ◽  
Akt Signaling ◽  
Network Pharmacology ◽  
Akt Signaling Pathway ◽  
Active Ingredients ◽  
Scutellariae Radix ◽  
Drug Ingredient

This study aims to analyze the targets of the effective active ingredients of Scutellariae radix-Coptidis rhizoma drug pair (SCDP) in ulcerative colitis (UC) by network pharmacology and molecular docking and to explore the associated therapeutic mechanism. The effective active ingredients and targets of SCDP were determined from the TCMSP database, and the drug ingredient-target network was constructed using the Cytoscape software. The disease targets related to UC were searched in GeneCards, DisGeNET, OMIM, and DrugBank databases. Then, the drug ingredient and disease targets were intersected to construct a protein-protein interaction network through the STRING database. The Metascape database was used for the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses of the predicted targets of SCDP for UC. The Autodock software was used for molecular docking between the main active ingredient and the core target to evaluate the binding ability. SCDP has 43 effective active ingredients and 134 intersection targets. Core targets included AKT1, TP53, IL-6, VEGFA, CASP3, JUN, TNF, MYC, EGFR, and PTGS2. GO functional enrichment analysis showed that biological process was mainly associated with a cytokine-mediated signaling pathway, response to an inorganic substance, response to a toxic substance, response to lipopolysaccharide, reactive oxygen species metabolic process, positive regulation of cell death, apoptotic signaling pathway, and response to wounding. KEGG enrichment analysis showed main pathway concentrations were related to pathways in cancer, AGE-RAGE signaling pathway in diabetic complications, bladder cancer, IL-17 signaling pathway, apoptosis, p53 signaling pathway, and PI3K-Akt signaling pathway. The drug active ingredient-core target-key pathway network contains 41 nodes and 108 edges, of which quercetin, wogonin, baicalein, acacetin, oroxylin A, and beta-sitosterol are important active ingredients; PTGS2, CASP3, TP53, IL-6, TNF, and AKT1 are important targets; and the pathways involved in UC treatment include pathways in cancer, PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic, apoptosis, IL-17 signaling pathway and herpes simplex infection. The active ingredient has a good binding capacity to the core target. SCDP key active ingredients are mainly quercetin, wogonin, baicalein, acacetin, oroxylin A, and beta-sitosterol, which function mainly by regulating targets, such as PTGS2, CASP3, TP53, IL-6, TNF, and AKT1, and are associated with multiple signaling pathways as pathways in cancer, PI3K-Akt signaling pathway, apoptosis, IL-17 signaling pathways.

Sign in / Sign up

Export Citation Format

Share Document